🌎🎉 We've recently announced the expansion of our partnership with Bio-Manguinhos / Fiocruz, which is the leading provider of vaccines and diagnostics to the Brazilian Ministry of Health, to enhance malaria and dengue detection across Brazil. Learn more about our partnership here 👉 https://lnkd.in/eptAVB_r 🤝 As your strategic partners, we are committed in providing custom solutions and innovations, technology transfer and long-term support. 📲📧 👉 Contact us at [email protected] to find how you can make an impact by collaborating with us. Together, let us make new strides and discovery in public health and diagnostics. 👨⚕️🏥👩⚕️ #QIAGEN #OEM #StrategicPartnership
🎉 We're thrilled to announce the expansion of our partnership with Bio-Manguinhos / Fiocruz, the leading provider of vaccines and diagnostics to the Brazilian Ministry of Health, to enhance malaria and dengue detection across Brazil. Learn more 👉 https://lnkd.in/eptAVB_r ✅ With the expansion of this collaboration, Bio-Manguinhos is now able to launch an advanced PCR-based screening platform deployed nationwide across 30 laboratories that provides new capabilities to detect malaria, HIV, HCV, and HBV in blood donations. ✅ Moreover, we're supporting epidemiological surveillance of Brazil’s ongoing dengue epidemic by developing Bio-Manguinhos/Fiocruz dengue molecular kits based on unique chemistry co-developed by our teams. ✅ This partnership highlights our commitment to custom and OEM by QIAGEN solutions, technology transfer, and long-term support. Together, we're making strides in public health and diagnostics.